NIVF
NewGenIvf Group Limited
NASDAQ · THHealthcareMedical - Healthcare Plans
$1.31-0.76%
Price as of Jul 20, 2026
NIVF growth
NewGenIvf Group Limited growth
Reported trailing growth, forward expectations and three-year compound growth rates.
Trailing growth
Year over year
- Revenue
- +258.9%
- EBITDA
- +1268.7%
- EBIT
- —
- EPS
- -79.8%
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -7.4%
- EBITDA
- +146.3%
- EBIT
- —
- Net income
- +178.2%
- EPS
- -35.5%
- Free cash flow
- —
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.